We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

Fund managers haven’t disclosed any holdings of ARKG yet.

ARKG Hedge Fund Activity: Q1 2026 in Review

218 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2026, worth a combined $743M — down 13% from $854M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of ARKG and 28 opened new positions — a net loss of 11 holders — while 55 trimmed existing stakes and 60 added.

The largest buyer was JP Morgan Chase, adding an estimated $61M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $59.2M.

  • 218 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2026, down from 238 in Q4 2025.
  • Funds reported $743M of ARK Genomic Revolution ETF stock for Q1 2026, down 13% quarter-over-quarter.
  • 28 funds opened new ARK Genomic Revolution ETF positions in Q1 2026 and 39 closed out, a net change of -11 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2026 was JP Morgan Chase, an estimated $61M added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2026 was BNP Paribas Financial Markets, an estimated $59.2M sold.

Based on aggregated 13F filings for Q1 2026.